Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Course of Intralesional Antimony for Bolivian Cutaneous Leishmaniasis

NCT01300975 is registered in ClinicalTrials.gov with Fundacion Nacional de Dermatologia as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01300975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Course of Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
Lead sponsor
Fundacion Nacional de Dermatologia
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2011
Completion date
July 31, 2012
Enrollment
90 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis, leishmaniasis